Medios Investor Relations Material
Latest events
Q1 2025
Medios
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Medios AG
Access all reports
Medios AG is a Germany-based company that engages in the wholesale of specialty pharmaceutical drugs. It offers a range of products, such as Asacol, Dornase alfa, Doxil, Fludara, Flumadine, and Multiplix. The company distributes products to hospitals and other health care providers. It also provides pharmacy services in hospitals and other health care institutions. The company was founded in 2016 and is based in Berlin, Germany.
Key slides for Medios AG
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
ILM1
Country
🇩🇪 Germany